Intellia Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA) (US 11,673,911) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 1 fee due Jan 11, 2027The maintenance fee for Polynucleotides, Compositions, and Methods for Genome Editing (US 11,697,806) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
- 1 fee due Apr 24, 2027The maintenance fee for Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis (US 11,795,460) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
- 1 fee due Jun 26, 2027The maintenance fee for Compositions and Methods for Immunooncology (US 11,851,659) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis (US 11,965,165) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 23, 2026
- Nov 10 US 12,790,624 Methods of Genotyping Adeno-Associated Virus Inverted Terminal Repeat Sequences in Plasmids Using Fixed Flanking Sequence Marker-Based Extraction and Clustering
- Nov 3 US 12,781,209 Compositions and Methods for Kallikrein (KLKB1) Gene Editing
- Sep 15 US 12,735,698 Modified Guide RNAs
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,173,284 | Modified Guide RNAs In force · Medium confidence | In force | Medium confidence | |
| US 12,735,698 | Modified Guide RNAs In force · Low confidence | In force | Low confidence | |
| US 12,460,205 | Compositions and Methods for Treating Alpha-1 Antitrypsin Deficiency In force · Medium confidence | In force | Medium confidence | |
| US 11,466,271 | Compositions and Methods for the Treatment of Hemoglobinopathies In force · High confidence | In force | High confidence | |
| US 11,795,460 | Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis In force · Medium confidence | In force | Medium confidence | |
| US 11,851,659 | Compositions and Methods for Immunooncology In force · High confidence | In force | High confidence | |
| US 12,391,722 | Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA) In force · Low confidence | In force | Low confidence | |
| US 11,965,165 | Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis In force · Medium confidence | In force | Medium confidence | |
| US 11,479,767 | Modified Guide RNAs In force · Medium confidence | In force | Medium confidence | |
| US 12,559,748 | Compositions and Methods for the Treatment of Hemoglobinopathies In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
35 pending · 27 abandoned · 1 no status recorded